Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU regulators to amend total joint reclassification proposal?

This article was originally published in Clinica

Executive Summary

With industry and regulators still at loggerheads over the joint UK and French authorities' proposal to raise all total joint replacements into a higher risk category, the European Commission's Reclassification Working Party has now worked out a possible compromise. It decided at a meeting on June 24 that its proposal for a Commission Directive on the reclassification of total joint replacements, already drafted, might stand more chance of being adopted without delay and without being caught up if it applied just to total hip, knees and shoulder joints.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT062782

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel